ReviewNeurochemical research2022

Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.

Dmytro I Boiko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.